Joint Confirms Board Election and Key Approvals

Joint ( (JYNT) ) has issued an announcement.

On May 21, 2025, Joint company held its annual meeting of stockholders where several key decisions were made. The election of seven directors to the Board was confirmed, with each nominee receiving the necessary votes to serve until the next annual meeting in 2026. Additionally, the compensation of named executive officers was approved, and the appointment of BDO USA, P.C. as the independent registered public accounting firm for the year ending December 31, 2025, was ratified.

The most recent analyst rating on (JYNT) stock is a Buy with a $15.00 price target. To see the full list of analyst forecasts on Joint stock, see the JYNT Stock Forecast page.

Spark’s Take on JYNT Stock

According to Spark, TipRanks’ AI Analyst, JYNT is a Neutral.

The overall stock score reflects significant financial challenges, including consistent net losses and declining revenues. Technical indicators suggest bearish momentum, and valuation metrics are unfavorable due to the negative P/E ratio. While the strategic shift to a franchisor model shows potential, current profitability issues and operational costs remain concerns. The earnings call provided some positive insights on revenue growth and cost management, but these are offset by declining EBITDA and sales in mature clinics.

To see Spark’s full report on JYNT stock, click here.

More about Joint

Average Trading Volume: 69,362

Technical Sentiment Signal: Sell

Current Market Cap: $155.2M

Learn more about JYNT stock on TipRanks’ Stock Analysis page.